We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AbbVie has had success growing Humira sales to the top position in biopharma globally, but a new lawsuit in California alleges the company used a massive fraud scheme to protect revenues at the expense of patient safety.